Talk Presenting Companies (Theatre B) track
Drug Discovery and Development: Orbis Medicines ApS
Mon, Nov 9, 2026 · 2:30–2:45 PM CET Koelnmesse
About this session
Our mission is to define a new era for macrocycle drugs and make great contributions to medicine. We are bringing together a world-class team to make this possible. Our broad pipeline is initially focused on delivering oral macrocycle candidates against targets validated by blockbuster biologic drugs in I&I and Cardiometabolic. The goal is to provide oral alternatives that provide meaningful value to healthcare and will enable the treatment of many more patients.
Speaker
-
VP Business Development · Orbis Medicines ApS
Speaker